Arcadia Biosciences Inc. (RKDA)
2.95
-0.02 (-0.67%)
At close: Mar 31, 2025, 3:42 PM
2.84
-3.73%
After-hours: Mar 31, 2025, 07:14 PM EDT
-0.67% (1D)
Bid | 2.68 |
Market Cap | 4.03M |
Revenue (ttm) | 5.28M |
Net Income (ttm) | -5.84M |
EPS (ttm) | -3.17 |
PE Ratio (ttm) | -0.93 |
Forward PE | -4.02 |
Analyst | Buy |
Ask | 3.38 |
Volume | 5,891 |
Avg. Volume (20D) | 9,050 |
Open | 2.95 |
Previous Close | 2.97 |
Day's Range | 2.58 - 2.97 |
52-Week Range | 1.85 - 10.31 |
Beta | 0.86 |
About RKDA
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, Californi...
Industry Agricultural Inputs
Sector Basic Materials
IPO Date May 15, 2015
Employees 9
Stock Exchange NASDAQ
Ticker Symbol RKDA
Website https://www.arcadiabio.com
Analyst Forecast
According to 1 analyst ratings, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 103.39% from the latest price.
Stock ForecastsNext Earnings Release
Arcadia Biosciences Inc. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+101.85%
Arcadia Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
4 months ago
-7.88%
Arcadia Biosciences shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss reported on Tuesday.